Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.
about
The Potential Use of Natural and Structural Analogues of Antimicrobial Peptides in the Fight against Neglected Tropical DiseasesStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewInhibition of influenza A virus infection in vitro by peptides designed in silicoAnalysis and prediction of highly effective antiviral peptides based on random forestsPeptide aptamers that bind to a geminivirus replication protein interfere with viral replication in plant cellsBats, emerging diseases, and the human interface.HIPdb: a database of experimentally validated HIV inhibiting peptides.Cell-penetrating and neurotargeting dendritic siRNA nanostructures.High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs AntagonistsRecent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain.Lyssaviruses.Peptide aptamers that bind to geminivirus replication proteins confer a resistance phenotype to tomato yellow leaf curl virus and tomato mottle virus infection in tomatoMultiple antigenic peptide (MAP): a synthetic peptide dendrimer for diagnostic, antiviral and vaccine strategies for emerging and re-emerging viral diseases.AVP-IC50 Pred: Multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50).AVPpred: collection and prediction of highly effective antiviral peptides.The rabies virus phosphoprotein synthesis and subcellular localization are modified by nerve growth factor.Inhibition of Rabies Virus by 1,2,3,4,6-Penta-O-galloyl-β-d-Glucose Involves mTOR-Dependent Autophagy.Advances in antiviral drug discovery and development: Part II: Advancements in antiviral drug developmentDendritische Nanostrukturen zur rezeptorvermittelten Aufnahme von siRNA in neurale Zellen
P2860
Q26797488-B53D906D-138B-44E7-B431-1583934999D6Q27008867-67AAA470-96FF-4A7E-AA24-53C8060D175BQ28534343-6A54D91A-8192-49AA-A2C1-D56CD9B8D54AQ28535105-C85D65A7-6A3F-40D5-9689-D0AAE13A895FQ33244997-8853D377-F864-4FDD-8E29-5B6434D6C741Q33487675-7DFEEB94-61A0-40C4-A615-99CB45F27820Q34566584-D71DB83D-201E-4BB4-A467-A8ED7B00B9F1Q35529832-FD1697A5-63B5-41B7-8758-83F378C6F1EAQ35634594-0D28B473-B29E-4406-8169-E0F8A1A70B42Q36491838-A31B29C1-3A1F-4452-9B86-E8B0B835C3BCQ37011499-69B93CD0-1F9F-4349-98A2-F07F57282AD9Q37123488-D7EA4687-0DE6-42D5-988A-EFBC76336931Q38178610-72CE54BF-FDC9-4000-B6FC-B903F0754AD8Q40693694-03D42849-13A2-479E-93DE-FA703CD08B8CQ42232907-93880C23-F66B-4D8A-A149-1B768682D1C0Q45386001-704D5DC6-566B-4FCB-A163-902C19F68882Q54232260-D28BB8CD-459D-4B95-9390-B37CBD91037EQ56749631-F4BB0650-CC69-4226-AC67-8DA859FE878EQ57077871-4C88D388-D9C0-4694-B5D8-16FA0C10E3B6
P2860
Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Antiviral drug discovery strat ...... cturally constrained peptides.
@ast
Antiviral drug discovery strat ...... cturally constrained peptides.
@en
type
label
Antiviral drug discovery strat ...... cturally constrained peptides.
@ast
Antiviral drug discovery strat ...... cturally constrained peptides.
@en
prefLabel
Antiviral drug discovery strat ...... cturally constrained peptides.
@ast
Antiviral drug discovery strat ...... cturally constrained peptides.
@en
P2093
P2860
P1433
P1476
Antiviral drug discovery strat ...... cturally constrained peptides.
@en
P2093
Corinne Jallet
Eléonore Real
Jacques D'Alayer
Jean-Christophe Rain
Noël Tordo
Peggy Chrisment
Pierre Legrain
Pierre Perrin
Véronique Battaglia
P2860
P304
P356
10.1128/JVI.78.14.7410-7417.2004
P577
2004-07-01T00:00:00Z